Sarepta Therapeutics Zooms Higher on Early Data Rally Promising
Sarepta Therapeutics surged about 20% after releasing early Phase 1/2 data for SRP-1001 and SRP-1003, signaling poten...
Explore how regular utility and phone bill payments can positively affect your credit when reported properly.
28,655 articlesSarepta Therapeutics surged about 20% after releasing early Phase 1/2 data for SRP-1001 and SRP-1003, signaling poten...
IMAX bucked trend as cinema operators fade; investors eye the premium-format chain's sale.
As market nerves remain tied to crude prices, the VanEck Energy Income ETF (EINC) continues to offer a solid 3.2%-3.6...
Ripple wins preliminary approval to operate under MiCA in Luxembourg, but the path to a full MiCA license is far from...
Nebius soars 16% after NVIDIA discloses a 9.3% stake, prompting a rally in AI cloud peers like CoreWeave and Oracle a...
As Friday marks the monthly expiry for a massive billion crypto options batch, traders brace for potential volatility...
Insider moves can reveal clues about a company's near-term prospects. This article dives into the remitly director's ...
Five years after a regulatory shock hit XRP, a $10,000 investment would have swung through a volatile ride. Here’s th...
Investors are debating whether removing the weakest members of the S&P 500 improves long-term results. Here's what th...
Applied Digital signals a slower AI data-center buildout through 2027 amid labor constraints, with hyperscalers pushi...
Policy experts say what trump's generic drug tariffs could mean for prices and supplies is uncertain, with effects de...
Tech-led losses push the Nasdaq lower as investors weigh rates and policy risks. Markets remain volatile as traders m...